JP5184783B2 - テトラヒドロビオプテリン、及びテトラヒドロビオプテリン類似体の製造方法 - Google Patents

テトラヒドロビオプテリン、及びテトラヒドロビオプテリン類似体の製造方法 Download PDF

Info

Publication number
JP5184783B2
JP5184783B2 JP2006539994A JP2006539994A JP5184783B2 JP 5184783 B2 JP5184783 B2 JP 5184783B2 JP 2006539994 A JP2006539994 A JP 2006539994A JP 2006539994 A JP2006539994 A JP 2006539994A JP 5184783 B2 JP5184783 B2 JP 5184783B2
Authority
JP
Japan
Prior art keywords
group
substituted
acetal
groups
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP2006539994A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007534637A5 (https=
JP2007534637A (ja
Inventor
モーザー，ルドルフ
グロエーン，ビオラ
シューマッハー，アンドレアス
マーティン，ピエール
シュピールフォーゲル，ディルク
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biomarin Pharmaceutical Inc
Original Assignee
Biomarin Pharmaceutical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomarin Pharmaceutical Inc filed Critical Biomarin Pharmaceutical Inc
Publication of JP2007534637A publication Critical patent/JP2007534637A/ja
Publication of JP2007534637A5 publication Critical patent/JP2007534637A5/ja
Application granted granted Critical
Publication of JP5184783B2 publication Critical patent/JP5184783B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D475/00—Heterocyclic compounds containing pteridine ring systems
    • C07D475/02—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4
    • C07D475/04—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4 with a nitrogen atom directly attached in position 2

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
JP2006539994A 2003-11-17 2004-11-17 テトラヒドロビオプテリン、及びテトラヒドロビオプテリン類似体の製造方法 Expired - Lifetime JP5184783B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US52036803P 2003-11-17 2003-11-17
US52036703P 2003-11-17 2003-11-17
US60/520,367 2003-11-17
US60/520,368 2003-11-17
PCT/US2004/038313 WO2005049614A2 (en) 2003-11-17 2004-11-17 Processes for preparing tetrahydrobiopterin, and analogs of tetrahydrobiopterin

Publications (3)

Publication Number Publication Date
JP2007534637A JP2007534637A (ja) 2007-11-29
JP2007534637A5 JP2007534637A5 (https=) 2008-01-17
JP5184783B2 true JP5184783B2 (ja) 2013-04-17

Family

ID=34623128

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006539994A Expired - Lifetime JP5184783B2 (ja) 2003-11-17 2004-11-17 テトラヒドロビオプテリン、及びテトラヒドロビオプテリン類似体の製造方法

Country Status (6)

Country Link
US (1) US7732599B2 (https=)
EP (1) EP1776364A2 (https=)
JP (1) JP5184783B2 (https=)
AU (1) AU2004290692A1 (https=)
CA (1) CA2545484A1 (https=)
WO (1) WO2005049614A2 (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL1708690T3 (pl) 2003-11-17 2017-01-31 Biomarin Pharmaceutical Inc. Leczenie fenyloketonurii za pomocą BH4
KR20070084270A (ko) 2004-11-17 2007-08-24 바이오마린 파머수티컬 인크. 안정한 정제 제형물
CA2675134A1 (en) * 2007-01-12 2008-07-24 Biomarin Pharmaceutical Inc. Pterin analogs
LT2545939T (lt) 2007-04-11 2021-03-10 Biomarin Pharmaceutical Inc. Tetrahidrobiopterinas, skirtas gydyti ligas, susijusias supadidėjusiu fenilalanino kiekiu
RU2470642C2 (ru) * 2008-01-03 2012-12-27 Байомарин Фармасьютикл Инк. Аналоги птерина для лечения состояния, чувствительного к вн4
BRPI0907247A2 (pt) 2008-01-07 2015-07-14 Biomarin Pharm Inc Métodos para preparar biopterina e para preparar tetraidrobiopterina
US9216178B2 (en) 2011-11-02 2015-12-22 Biomarin Pharmaceutical Inc. Dry blend formulation of tetrahydrobiopterin
CN102633799B (zh) * 2012-04-10 2014-06-25 凯莱英医药集团（天津）股份有限公司 一种从消旋体中间体拆分路线合成二盐酸沙丙蝶呤的方法
CN104736539B (zh) 2012-05-07 2017-09-01 白鸟制药株式会社 墨蝶呤和四氢乳酰蝶呤的制造法
WO2016189542A1 (en) 2015-05-28 2016-12-01 Natco Pharma Ltd Novel process for the preparation of sapropterin dihydrochloride and its key intermediate, l-biopterin
IL305149A (en) 2016-07-26 2023-10-01 Biomarin Pharm Inc Novel adeno-associated virus capsid proteins
MA46973A (fr) 2016-11-29 2019-10-09 Censa Pharmaceuticals Inc Polymorphes de sépiaptérine et leurs sels
MA46972A (fr) 2016-11-29 2019-10-09 Censa Pharmaceuticals Inc Forme polymorphe de sépiaptérine
JP7811085B2 (ja) 2017-09-01 2026-02-04 ピーティーシー セラピューティクス エムピー，インコーポレイテッド セピアプテリンを含む医薬組成物及びその使用
TW202016314A (zh) 2018-05-09 2020-05-01 美商拜奧馬林製藥公司 治療苯丙酮尿症之方法
TW202005978A (zh) 2018-05-14 2020-02-01 美商拜奧馬林製藥公司 新穎肝靶向腺相關病毒載體
FI3801536T3 (fi) 2018-05-30 2024-08-29 Ptc Therapeutics Mp Inc Sepiapteriinin antaminen ilman ruokaa käytettäväksi menetelmässä sepiapteriinin plasma-altistuksen lisäämiseksi
EP3801534B1 (en) 2018-05-30 2026-02-18 PTC Therapeutics MP, Inc. Treatment of phenylketonuria with sepiapterin
TW202144575A (zh) 2020-04-03 2021-12-01 美商拜奧馬林製藥公司 使用ａａｖ及治療調配物之苯酮尿症治療
GB202307239D0 (en) 2023-05-15 2023-06-28 Evox Therapeutics Ltd Gene therapies for Phenylketonuria

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS617287A (ja) 1984-06-21 1986-01-13 Kanegafuchi Chem Ind Co Ltd ５‐デオキシ‐ｌ‐アラビノースの製造法
JP2575781B2 (ja) * 1988-02-29 1997-01-29 日清製粉株式会社 ２，３−ジアシルオキシ−４−ヒドロキシ−トペンタナールおよびその製造方法

Also Published As

Publication number Publication date
WO2005049614A3 (en) 2007-03-08
EP1776364A2 (en) 2007-04-25
CA2545484A1 (en) 2005-06-02
JP2007534637A (ja) 2007-11-29
US20070244322A1 (en) 2007-10-18
WO2005049614A2 (en) 2005-06-02
US7732599B2 (en) 2010-06-08
AU2004290692A1 (en) 2005-06-02

Similar Documents

Publication Publication Date Title
JP5184783B2 (ja) テトラヒドロビオプテリン、及びテトラヒドロビオプテリン類似体の製造方法
CN101657462A (zh) 卡培他滨的制备方法及其中间体
BG62810B1 (bg) Метод за диастереоселективно получаване на нуклеозиднианалози
ES2923278T3 (es) Intermedios útiles para la síntesis de derivados de aminopirimidinas, proceso de preparación del mismo y proceso de preparación de aminopirimidina derivados utilizando los mismos
JP5781923B2 (ja) シグマ受容体阻害剤の合成に有用なナフタレン−２−イル−ピラゾール−３−オン中間体の調製のためのプロセス
KR20090066910A (ko) Ｌ-3-ｏ-치환-아스코르브산의 개선된 제조방법
US5043446A (en) Process for the preparation of pterin derivatives
KR101012134B1 (ko) 이마티니브 및 이마티니브 메실레이트염의 제조방법
JP2001261653A5 (https=)
JPWO2001062769A1 (ja) インドロピロロカルバゾール誘導体の製造法、その製造中間体及びその製造法
WO2010079813A1 (ja) イノシン誘導体の製造方法
WO2024126771A1 (en) Process for preparing (z)-3-(2-(5-bromo-1h-indol-3-yl)-2-cyanovinyl)-4-methoxybenzonitrile
JP4278316B2 (ja) ヒドラジン誘導体の製造方法
JP4491104B2 (ja) カルボニル化合物の製造方法
US6632943B2 (en) Process for production of optically active pyrroloazepine derivatives
KR20250174969A (ko) 올리고뉴클레오티드 유사체 또는 이의 염을 제조하기 위한 중간체 및 이의 제조 방법
KR101388770B1 (ko) 신규 중간체 화합물을 이용한 우로카닌산의 제조방법
JPWO2001044251A1 (ja) 光学活性ピロロアゼピン誘導体の製造方法
WO2004065386A1 (ja) ２,６−ジハロゲノ−８−置換−プリン化合物およびその製造方法
JPS62192361A (ja) ピラゾ−ル類とその製法
JP2001226394A (ja) ２’−デオキシ−β−グアノシンの製造法およびその中間体
JPH066549B2 (ja) ２−ヒドロキシメチル−２，５，１２−トリヒドロキシ−１，２，３，４−テトラヒドロナフタセン−６，１１−ジオンの製造方法
JPWO1996001263A1 (ja) インドロカルバゾール誘導体の製造法
JPWO2006137447A1 (ja) シュードウリジン保護体の安定結晶
KR20020041521A (ko) 신규한 인돌 히드라존 유도체

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20071116

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20071116

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110524

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20110823

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20110830

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20111114

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120424

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20120723

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20120730

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20121024

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20121218

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20130117

R150 Certificate of patent or registration of utility model

Ref document number: 5184783

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20160125

Year of fee payment: 3

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term